DRI busts Ambernath drug unit, seizes 2 lakh tablets in Nigeria export bid
Synopsis
Key Takeaways
The Directorate of Revenue Intelligence (DRI) dismantled a clandestine narcotic drug manufacturing network in Ambernath, Maharashtra, seizing 2 lakh tablets of controlled psychotropic substances and arresting three key accused who had allegedly attempted to smuggle the drugs to Nigeria, officials said on Monday, 10 August. The week-long intelligence-led operation foiled what authorities described as an organised transnational trafficking attempt.
How the Operation Unfolded
The case began on 2 August when DRI officers intercepted a suspicious export consignment at the Mumbai Air Cargo Complex bound for Nigeria. The shipment had been declared as containing Pregabalin capsules — 300 mg, but a detailed physical examination revealed a very different cargo concealed within.
Officers recovered 1 lakh Tramadol Hydrochloride tablets (250 mg, approximately 25 kg) and 1 lakh Tapentadol tablets (200 mg, approximately 20 kg) — both scheduled psychotropic substances — hidden inside the consignment. The tablets had been packed in plain cartons to obscure their identity and subsequently repacked in white gunny bags at a warehouse near the air cargo complex ahead of the attempted illegal export.
The Clandestine Factory in Ambernath
Follow-up searches conducted across multiple locations over the course of the week led investigators to a manufacturing facility in Ambernath. Searches at the site resulted in the seizure of tablet compression machinery along with substantial quantities of raw materials intended for the clandestine production of psychotropic substances.
According to the DRI statement, the Tramadol tablets were manufactured at this factory and transported to a warehouse near the Mumbai Air Cargo Complex, where they were prepared for illegal export. The entire supply chain — from manufacture to warehousing to attempted export — was reportedly coordinated by the arrested syndicate.
Three Key Accused Arrested
The operation culminated in the arrest of three individuals identified as central figures in the network: the Importer-Exporter Code (IEC) holder and exporter, the supplier-cum-coordinator, and the clandestine manufacturer of the Tramadol tablets. DRI said searches were carried out at locations linked to the exporter, manufacturer, supplier, transporter, and storage warehouse.
Legal Status of the Seized Substances
Tramadol has been notified as a psychotropic substance under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985, making its illicit manufacture and trafficking a serious criminal offence. Tapentadol, while not currently listed in the NDPS Act schedule, is strictly regulated under the Drugs and Cosmetics Act and its associated rules.
Both Tramadol and Tapentadol are synthetic opioid analgesics prescribed under medical supervision for moderate to severe pain management. Their significant abuse potential and risk of dependence place them under stringent regulatory oversight, the DRI noted.
Part of a Wider Crackdown
The DRI described this operation as part of its sustained campaign against the illicit manufacture and transnational trafficking of narcotic drugs and psychotropic substances. Authorities warned that the diversion and trafficking of such medicines pose a serious public health threat and are frequently linked to organised cross-border drug networks. Further investigations into the syndicate's wider connections remain ongoing.